siRNA, Anti-C21orf2, LNA-modified(CAT#: SIRGT04504WQ-LNA)

The product SIRGT04504WQ-LNA is a type of small interfering RNA (siRNA) that targets C21orf2 gene and regulates the expression of gene. The siRNA interferes with the expression of C21orf2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001271440.1; NM_001271441.1; NM_001271442.1; NM_004928.2
Alternative Names LRRC76; RDMS; SMDAX; YF5/A2
Related Diseases Retinal Dystrophy, Spondylometaphyseal Dysplasia
Purification HPLC
Target Gene
Gene ID 755
Uniprot ID O43822

Related Products